Skip to main content
GLMD
NASDAQ Life Sciences

Galmed Finalizes Colospan Acquisition with Anti-Dilutive Terms, Boosting Shareholder Value

Tom Rudovsky · Reported by PR Newswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
9
Price
$0.61
Mkt Cap
$4.457M
52W Low
$0.411
52W High
$2.34
52W Position info
48% above low
Off High info
74% below high
Rel. Volume
Market data snapshot near publication time

GLMD sits 48% above its 52-week low of $0.411.

Summary

Galmed Pharmaceuticals has finalized its acquisition of Colospan Ltd., restructuring the deal to be less dilutive for shareholders. The original $2.0 million stock issuance was replaced with an $800K cash payment and a performance-based earnout capped at $2.0 million, commencing in Q3 2027. This follows the initial acquisition announcement on June 8th and is a material financial adjustment for the company, explicitly aimed at protecting shareholder value. The acquisition establishes a new GI-focused platform with Colospan's commercially ready CG-100 device, which is expected to generate revenue in Europe as early as 2026.

At the time of this announcement, GLMD was trading at $0.61 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $4.5M. The 52-week trading range was $0.41 to $2.34. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: PR Newswire.


Price Chart

Share this article

Copied!

GLMD - Latest Insights

GLMD
Sep 08, 2026, 6:08 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $4.30
Real-time Price: $4.66 info
Change: +$0.360 (+8%) info
Market Cap: $4.822M info
GLMD
Sep 02, 2026, 4:20 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $4.12
Real-time Price: $4.66 info
Change: +$0.541 (+13%) info
Market Cap: $4.822M info
GLMD
Aug 19, 2026, 7:05 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $0.513
Real-time Price: $4.66 info
Change: Reverse Stock Split info
Market Cap: $4.822M info
GLMD
Aug 17, 2026, 9:23 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $0.5145
Real-time Price: $4.66 info
Change: Reverse Stock Split info
Market Cap: $4.822M info
GLMD
Aug 17, 2026, 9:20 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $0.5206
Real-time Price: $4.66 info
Change: Reverse Stock Split info
Market Cap: $4.822M info